Commission Implementing Decision of 1 July 2014 authorising the placing on the market of rapeseed protein as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2014) 4256) (Only the German text is authentic) (2014/424/EU)
Grade B
mapped from publisher markup. A grade says how a document's structure was obtained, not how reliable the law is.
Address https://gelex.eu/eli/EU/decision/2014/424@2014-07-01/en
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and novel food ingredients, and in particular Article 7 thereof,
Whereas:
(1) On 25 June 2012, the company Helm AG made a request to the competent authorities of Ireland to place rapeseed protein on the market as a novel food ingredient. Rapeseed protein is intended to be used as a vegetable protein source in foods except in infant formulae and follow-on formulae. On 18 February 2014, the Commission was notified that Siebte PMI Verwaltungs GmbH had acquired the rights to the pending request.
(2) On 17 September 2012, the competent food assessment body of Ireland issued its initial assessment report. In that report it came to the conclusion that rapeseed protein meets the criteria for novel food set out in Article 3(1) of Regulation (EC) No 258/97.
(3) On 4 October 2012, the Commission forwarded the initial assessment report to the other Member States.
(4) Reasoned objections were raised within the 60-day period laid down in the first subparagraph of Article 6(4) of Regulation (EC) No 258/97.
(5) On 14 February 2013, the Commission consulted the European Food Safety Authority (EFSA) asking it to carry out an additional assessment for rapeseed protein as food ingredient in accordance with Regulation (EC) No 258/97.
(6) On 10 October 2013, in its Scientific Opinion on the safety of rapeseed protein isolate as the Novel Food ingredient, EFSA concluded that rapeseed protein is safe as a protein added to food. However, it also noted that the risk of sensitisation to rapeseed cannot be excluded and that it is likely that rapeseed can trigger allergic reactions in people allergic to mustard.
(7) Therefore, the opinion gives sufficient grounds to establish that rapeseed protein as a novel food ingredient complies with the criteria laid down in Article 3(1) of Regulation (EC) No 258/97, provided that the labelling of foods containing rapeseed protein as a food ingredient is such to allow people who are allergic to mustard to avoid consumption of those foods.
(8) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,
HAS ADOPTED THIS DECISION:
Article 1
Rapeseed protein specified in the Annex may be placed on the market in the Union as a novel food ingredient.
Article 2
The designation of rapeseed protein authorised by this Decision on the labelling of the foodstuffs containing it shall be rapeseed protein.
Article 3
The labelling of any foodstuff containing rapeseed protein shall bear an easily visible and legible statement that the product containing rapeseed protein as a food ingredient may cause allergic reaction to consumers who are allergic to mustard and products thereof. Where relevant, this statement shall appear in close proximity to the list of ingredients.
Article 4
This Decision is addressed to Siebte PMI Verwaltungs GmbH, Neuer Jungfernstieg 5, 20354 Hamburg, Germany.
Done at Brussels, 1 July 2014. For the Commission Tonio Borg Member of the Commission
ANNEX
ANNEX SPECIFICATION OF RAPESEED PROTEIN
Definition Rapeseed protein is an aqueous protein-rich extract from rapeseed press cake originating from non-genetically modified Brassica napus L. and Brassica rapa L. Description White to off-white, spray dried powder. Total protein Not less than 90 % Soluble protein Not less than 85 % Moisture Not more than 7 % Carbohydrates Not more than 7 % Fat Not more than 2 % Ash Not more than 4 % Fibre Not more than 0,5 % Total glucosinolates Not more than 1 mmol/l Purity Total phytate Not more than 1,5 % Lead Not more than 0,5 mg/kg Microbiological criteria Yeast and mould count Not more than 100 cfu/g Aerobic bacteria count Not more than 10000 cfu/g Total coliform count Not more than 10 cfu/g Escherichia coli Absent in 10 g Salmonella spp. Absent in 25 g
Versions
Cited by
- Commission Implementing Regulation (EU) 2021/120 of 2 February 2021 authorising the placing on the market of partially defatted rapeseed powder from Brassica rapa L. and Brassica napus L. as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance) Regulation · Grade B
The applicant also proposed that, because the protein fraction of the partially defatted rapeseed powder from Brassica rapa L. and Brassica napus L. is similar to that of the rapeseed protein authorised as a novel food by Commission Implementing Decision 2014/424/EU for which the European Food Safety Authority (the Authority) had concluded that a risk of sensitisation cannot be excluded and that it is likely that it can trigger allergic reactions in people allergic to mustard, the labelling of food products containing partially defatted rapeseed powder from Brassica rapa L. and Brassica napus